New imaging technique could reveal how breast cancer drugs work inside the body
NCT ID NCT02608216
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 28 times
Summary
This study uses a special PET scan called FLT PET/CT to look at how active breast cancer tumors are before and during treatment with two drugs (ribociclib and paclitaxel). About 20 adults with metastatic breast cancer that has spread beyond the liver and bones will take part. The goal is to see if the scan can show early signs of whether the treatment is working, which may help doctors personalize care in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Pennsylvania Hospital
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.